Skip to main content
Novartis AG (NVS)
NYSE: NVS · Real-Time Price · USD
104.72
-0.03 (-0.03%)
At close: Jan 31, 2025, 4:00 PM
104.52
-0.20 (-0.19%)
After-hours: Jan 31, 2025, 7:09 PM EST

Novartis AG Revenue

In the year 2024, Novartis AG had annual revenue of $51.72B with 10.85% growth. Novartis AG had revenue of $13.56B in the quarter ending December 31, 2024, with 15.13% growth.

Revenue (ttm)
$51.72B
Revenue Growth
+10.85%
P/S Ratio
n/a
Revenue / Employee
$681,602
Employees
75,883
Market Cap
207.60B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202451.72B5.06B10.85%
Dec 31, 202346.66B3.20B7.36%
Dec 31, 202243.46B-513.00M-1.17%
Dec 31, 202143.97B-5.92B-11.87%
Dec 31, 202049.90B1.22B2.51%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Thermo Fisher Scientific 42.88B
Abbott Laboratories 41.95B
Eli Lilly and Company 40.86B
Revenue Rankings

NVS News

More News